Sun Pharmaceutical Industries Ltd.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that the schedule of Analyst/Institutional Investor Meeting with the Company to be held on 23-August-2023.

The above information is a part of company’s filings submitted to BSE.